Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma

被引：0
|
作者：
Sarah Bouchereau
Louise Chaplain
Magali Fort
Alain Beauchet
Thomas Sidibé
Marie Chapalain
Leire Gonzalez-Lara
Christine Longvert
Astrid Blom
Philippe Saiag
Elisa Funck-Brentano
机构：
[1] Ambroise Paré Hospital,Department of General and Oncologic Dermatology
[2] AP-HP,Department of Public Health
[3] Research unit EA4340 ‘Biomarkers and clinical trials in cancerology and onco-hematology’,Department of Pharmacy
[4] Versailles-Saint-Quentin-en-Yvelines University,undefined
[5] Paris-Saclay University,undefined
[6] GHU Paris-Saclay,undefined
[7] AP-HP,undefined
[8] Ambroise Paré Hospital,undefined
[9] AP-HP,undefined
来源：
British Journal of Cancer | 2021年 / 125卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：948 / 954
页数：6
相关论文
共 50 条
  • [31] The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
    Li, Ping
    Yang, Xuefang
    Feng, Yumiao
    Wu, Lijuan
    Ma, Wei
    Ding, Gaozhong
    Wei, Yun
    Sun, Lan
    ONCOTARGETS AND THERAPY, 2018, 11 : 7521 - 7527
  • [32] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Efficacy of immune checkpoint inhibitors for treating uveal melanoma metastases
    Oxenreiter, Monica
    Lane, Anne Marie
    Cohen, Justine V.
    Sullivan, Ryan J.
    Kim, Ivana K.
    Gragoudas, Evangelos S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Melanoma and Immune Checkpoint Inhibitors
    Masutaka Furue
    Takamichi Ito
    Naoko Wada
    Maiko Wada
    Takafumi Kadono
    Hiroshi Uchi
    Current Oncology Reports, 2018, 20
  • [35] Immune checkpoint inhibitors in melanoma
    Carlino, Matteo S.
    Larkin, James
    Long, Georgina V.
    LANCET, 2021, 398 (10304): : 1002 - 1014
  • [36] Immune checkpoint inhibitors in melanoma
    Cooper, Adam J.
    Carlino, Matteo S.
    Kefford, Richard F.
    MELANOMA MANAGEMENT, 2015, 2 (03) : 267 - 284
  • [37] Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists
    Kakavand, Hojabr
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    PATHOLOGY, 2016, 48 (02) : 194 - 202
  • [38] Melanoma and Immune Checkpoint Inhibitors
    Furue, Masutaka
    Ito, Takamichi
    Wada, Naoko
    Wada, Maiko
    Kadono, Takafumi
    Uchi, Hiroshi
    CURRENT ONCOLOGY REPORTS, 2018, 20 (03)
  • [39] Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)
    Guerra, Veronica
    Ologun, Gabriel
    Haydu, Lauren
    Keung, Emily
    Burton, Elizabeth
    Tawbi, Hussein
    Davis, Michael
    Wargo, Jennifer
    Ferrajoli, Alessandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S225 - S225
  • [40] Posterior cord syndrome associated with immune checkpoint inhibitors for metastatic melanoma
    Secco, L. -p.
    Lesage, C.
    Lippi, A.
    Maria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (03): : 193 - 194
12345